Welcome to our dedicated page for Dassault Systemes news (Ticker: DASTY), a resource for investors and traders seeking the latest updates and insights on Dassault Systemes stock.
Dassault Systèmes (DASTY) drives industrial innovation through its 3DEXPERIENCE platform, enabling virtual twin experiences that transform product design and manufacturing processes. This news hub provides investors and industry professionals with essential updates about the company developments shaping digital transformation across aerospace, automotive, and life sciences sectors.
Access official press releases and curated analysis covering strategic partnerships, technology advancements, and financial performance. Our comprehensive collection helps stakeholders track innovations in simulation software, collaborative product lifecycle management, and sustainable production methodologies central to DASTY's market leadership.
Discover updates about the 3DEXPERIENCE ecosystem's impact on digital twin adoption, cloud-based design solutions, and cross-industry applications. Content is organized for efficient navigation while maintaining technical accuracy for engineering professionals and accessibility for general investors.
Bookmark this page for direct access to Dassault Systèmes' latest announcements. Monitor how the company's integrated approach to virtual design continues redefining industrial innovation standards worldwide.
The global electronic clinical outcome assessment solutions market is projected to grow significantly, reaching USD 6.27 billion by 2032. Key drivers include an increase in clinical trials, enhanced compliance, and the demand for effective clinical data management. The adoption of eCOA technologies is bolstered by the complexity of healthcare information management and regulatory requirements emphasizing patient well-being assessments. The market is expected to be led by web and cloud-based solutions, with North America dominating due to key initiatives. Key players include Paraxel International Corporation and CRF Health.
Dassault Systèmes has filed its 2022 Universal Registration Document on March 17, 2023, with the Autorité des marchés financiers. This document serves as the Annual Financial Report and is available on their website. Key components of the filing include the 2022 Annual Financial Report, the Board of Directors’ Report on corporate governance, and details regarding the proposed share repurchase program for the General Shareholders’ Meeting. Hard copies can be requested at Dassault Systèmes’ headquarters in France.
The global market for Computational Fluid Dynamics (CFD) is projected to grow from
The global Quality and Lifecycle Management Software Market is projected to grow from USD 24.6 billion in 2022 to USD 34.9 billion by 2027, at a CAGR of 7.2%.
Key growth drivers include increased demand for smart devices, low manufacturing costs, and a surge in small and medium business needs.
Quality management software is essential for reducing costs and improving product quality, particularly in the consumer goods and retail sectors, which are expected to see the highest growth. The North American market will lead in size, aided by advanced technologies and significant IT spending.
On March 15, 2023, Dassault Systèmes announced a new global employee shareholding program aimed at involving approximately 99% of its employees worldwide. Following a successful program in 2021, the upcoming offering will involve a capital increase of up to 7 million shares, set to occur on June 15, 2023. The subscription price will be 85% of the weighted average share price from April 18 to May 16, 2023. This initiative highlights the company's commitment to inclusive growth and aligns employees more closely with the company's success.
Dassault Systèmes has announced a proposed dividend of €0.21 per share for FY2022, to be voted on at the General Meeting on May 24, 2023. The stock will trade ex-dividend starting May 29, 2023, with payments made on May 31, 2023. CEO Bernard Charlès emphasized the company is ahead of its deleveraging schedule and is committed to its dividend policy while maintaining investment capacity for long-term strategies. This dividend proposal reflects the company’s operational performance and ongoing confidence.
The global material informatics market is projected to expand from USD 129 million in 2023 to USD 276 million by 2028, reflecting a CAGR of 16.3%. Key market players include Dassault Systemes (DASTY), Mat3ra, and Citrine Informatics. The increasing use of AI/ML in research and development across various sectors like chemical and pharmaceutical is driving this growth. North America is expected to dominate the market, followed by significant growth in the Asia-Pacific region. However, challenges like a shortage of technical resources and high maintenance costs could impact progress.
Dassault Systèmes announced the total number of outstanding shares and voting rights as of February 28, 2023. The company has 1,335,275,553 outstanding shares and 2,001,539,405 voting rights. This announcement complies with the General Regulation of the Autorité des marchés financiers. The voting rights are calculated based on the outstanding shares, irrespective of any suspended rights. Shareholders are reminded to report any crossing of thresholds as outlined in Article 223-11 of the regulations. For further inquiries, shareholders can contact the Investor Relations Service via email.
The global digital twin market was valued at
North America accounted for 34.1% of the market share in 2021, while Asia Pacific and North America are forecasted as the fastest-growing regions. The digital twin market is segmented into product, process, and system digital twins, with the system segment leading.
The Medical Equipment Reports Subscription by ResearchAndMarkets.com offers access to 7 industry reports covering various sectors of the medical equipment market. Subscribers can choose from areas such as Home Oxygen Equipment, Monitoring Devices, and Surgical Robots, with data on market shares and forecasts from 2022 to 2028. The subscription provides an annual update for each selected report. This initiative aims to support clinical caregivers and enhance the quality of care by leveraging innovative medical devices for chronic disease management.